{"id":85750,"date":"2025-07-11T04:00:26","date_gmt":"2025-07-11T02:00:26","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?p=85750"},"modified":"2025-07-23T17:10:41","modified_gmt":"2025-07-23T15:10:41","slug":"the-case-for-early-data-management-input-in-ecoa","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/eu\/blog\/the-case-for-early-data-management-input-in-ecoa\/","title":{"rendered":"The Case for Early Data Management Input in eCOA"},"content":{"rendered":"

The life science industry stands at a critical point in its approach to electronic clinical outcome assessment (eCOA) data. Despite the technology\u2019s maturity, eCOA adoption lags behind other clinical trial systems. While the shift away from paper-based methods has brought advancements, there is scope to improve eCOA data capture and management strategies. These limitations contribute to restricted scalability, escalating costs, and protracted timelines in clinical trials. A significant factor in these challenges is the belated involvement of data managers in the eCOA process.<\/p>\n

Traditionally, data management\u2019s role has been largely back ended, working with the data once collected; their strategic input earlier in the process holds the key to better upfront decisions and streamlined downstream processes. A fundamental shift in our view of eCOA data management and a re-evaluation of when and where each stakeholder should contribute their expertise is required.<\/p>\n

Rethinking the current approach<\/h2>\n

The clinical data landscape has changed considerably over the last decade. Historically, the majority of data came from site-based entry and all data was handled in a similar way, regardless of source.<\/p>\n

As technology evolves, the amount of data collected through electronic data capture systems (EDCs) is reducing while the eCOA proportion of the data set is increasing. This is in part due to the move away from paper, but also because the industry is realizing the value of the patient voice in clinical research. Therefore, the design, capture, and management of eCOA is becoming more important. However, eCOA systems and processes haven\u2019t kept pace with tools like EDC. Why?<\/p>\n

The current model for eCOA implementation means systems are adopted on a study-by-study basis, impacting standardization across studies. A lack of data flow from siloed systems leads to poor data access, and delayed data manager involvement often leads to sub-optimal data structure, increasing work later in the process. Together with a heavy reliance on eCOA vendors, these challenges result in minimal scalability, longer timelines, increased cost, and greater burden on sites and patients.<\/p>\n

Changing mindsets about how eCOA is designed, delivered, and managed can be daunting. Taking a new approach that enables eCOA standardization across studies overcomes the traditional barriers of slow builds, limited data access, and onerous data management processes.<\/p>\n

Standardizing the three pillars of eCOA data management<\/h2>\n

Building a better eCOA that reduces the burden on study teams and improves patient experience relies on standardizing the three pillars of eCOA data management:<\/p>\n